| 发明名称 |
HEMOSTATIC FOAM |
| 摘要 |
The invention discloses a pharmaceutical hemostatic liquid foam base preparation comprising albumin as foaming agent and a fibrinogen precipitating substance and optionally a coagulation inducing agent, wherein albumin as foaming agent is present in native form; a method for the production of a transient hemostatic liquid foam; the transient hemostatic liquid foam; and a kit for making the foam. |
| 申请公布号 |
US2014161738(A1) |
申请公布日期 |
2014.06.12 |
| 申请号 |
US201314099712 |
申请日期 |
2013.12.06 |
| 申请人 |
Baxter Healthcare S.A. ;Baxter International Inc. |
发明人 |
Goessl Andreas;Gorna Katarzyna |
| 分类号 |
A61L26/00 |
主分类号 |
A61L26/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical hemostatic liquid foam base preparation comprising albumin as foaming agent and a fibrinogen precipitating substance, wherein albumin as foaming agent is present in native form.
|
| 地址 |
Glattpark (Opfikon) CH |
